Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288726 | 0.85 | MGLL (0.36) | MAPTCA12CA7CA14KDM4E | |
| Hydrochloric Acid SCHEMBL14919371 | 0.83 | MGLL (0.35) | MAPTCA12CA7CA14 | |
| SCHEMBL10388498 | 0.70 | — | — | |
| SCHEMBL10491849 | 0.69 | CA12 (0.33) | MAPTCA12CA7CA14 | |
| SCHEMBL6394343 | 0.67 | SMN1; SMN2 (0.35) | MAPTCA12CA7CA14 | |
| SCHEMBL28389787 | 0.67 | KDM4E (0.42) | MAPTCA12KDM4E | |
| SCHEMBL6759923 | 0.65 | MAPT (0.34) | MAPTCA12CA7CA14 | |
| SCHEMBL6551832 | 0.65 | SMN1; SMN2 (0.34) | MAPTCA12CA7CA14 | |
| SCHEMBL1287869 | 0.65 | MAPT (0.34) | MAPTCA12CA7CA14 | |
| SCHEMBL1042877 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118354997-A | Process for producing high purity N, N-dialkyl perfluoroalkyl sulfonamides | 麻省固能控股有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-11680041-B1 | Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide | SES HOLDINGS PTE. LTD. (SG) | 2023-06-20 | — | — | US | claimed |
| WO-2023105411-A1 | PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE | SES HOLDINGS PTE. LTD. (SG) | 2023-06-15 | — | — | WO | claimed |
| US-20230174469-A1 | Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide | SES HOLDINGS PTE. LTD. (SG) | 2023-06-08 | — | — | US | claimed |
| CN-118354997-A | Process for producing high purity N, N-dialkyl perfluoroalkyl sulfonamides | 麻省固能控股有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-11680041-B1 | Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide | SES HOLDINGS PTE. LTD. (SG) | 2023-06-20 | — | — | US | disclosed |
| WO-2023105411-A1 | PROCESSES FOR PRODUCING HIGH-PURITY N, N-DIALKYL PERFLUOROALKYL SULFONAMIDE | SES HOLDINGS PTE. LTD. (SG) | 2023-06-15 | — | — | WO | disclosed |
| US-20230174469-A1 | Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide | SES HOLDINGS PTE. LTD. (SG) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680041-B1 | Processes for producing high-purity N,N-dialkyl perfluoroalkylsulfonamide | RFC2, AFF2, AFF1 | MAPT 4850/4885CA12 1806/4885CA7 2465/4885 |
| US-20230174469-A1 | Processes For Producing High-Purity N,N-Dialkyl Perfluoroalkylsulfonamide | RFC2, AFF2, AFF1 | MAPT 4850/4885CA12 1806/4885CA7 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.